Evidence map›Paper›PMID 42641934›Full record

ArticleAmerican journal of obstetrics and gynecology2026

Endometriosis risk factors and comorbidities by endometriosis lesion macrophenotypes: an analysis from the What is Endometriosis (WisE) study.

Naoko Sasamoto, Amy L Shafrir, Christine B Sieberg, Allison F Vitonis, Nan Lin, Mary DePari, Sara R Till, Amy D DiVasta, Kurtis Garbutt, Katy Vincent and 4 more

Abstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Naoko SasamotoProgram in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA; Boston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA. Electronic address: nsasamot@fredhutch.org.
Amy L ShafrirBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Department of Health Sciences and Nutrition, School of Nursing and Health Sciences, Merrimack College, North Andover, MA; Division of Adolescent and Young Adult Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Christine B SiebergDepartment of Psychiatry, Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
Allison F VitonisBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.
Nan LinDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.
Mary DePariBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.
Sara R TillDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.
Amy D DiVastaBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Division of Adolescent and Young Adult Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Kurtis GarbuttOxford Endometriosis Care and Research Centre, Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom.
Katy VincentOxford Endometriosis Care and Research Centre, Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom.
Christian BeckerOxford Endometriosis Care and Research Centre, Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom.
Krina T ZondervanOxford Endometriosis Care and Research Centre, Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom.
Kathryn L TerryBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Stacey A MissmerBoston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, Grand Rapids, MI. Electronic address: missmer@med.umich.edu.

Funding

What is Endometriosis? Deep Phenotyping to Advance Diagnosis and TreatmentR01HD094842 · NICHD · MICHIGAN STATE UNIVERSITY · PI FAZLEABAS, ASGERALLY T., MISSMER, STACEY ANN · 2018 to 2022
$4.2M
NICHD NIH HHS R01 HD094842
6 · The paper itself

Abstract

backgroundWhile endometriosis is thought to be a heterogeneous disease, the pathophysiologic heterogeneity across the 3 visualized lesion macrophenotypes (ie, superficial peritoneal endometriosis lesions, endometriomas, and deep lesions) remains unclear.

objectiveThis study aimed to investigate associations between known and putative risk factors and coexisting comorbidities with odds of endometriosis lesion macrophenotypes. STUDY

designWe conducted a pooled, cross-sectional analysis using data from 1244 participants surgically diagnosed with endometriosis and 1271 without endometriosis who participated in 3 World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project compliant population-based studies from North America and Europe. Multivariable logistic regression models adjusting for age at questionnaire completion and studies were used to calculate odds ratios and 95% confidence intervals for the associations between participant characteristics of known and putative risk factors and coexisting comorbidities and surgically-confirmed endometriosis. Polytomous logistic regression was used to examine the associations among case groups defined by endometriosis macrophenotype, with likelihood ratio tests used to evaluate statistically significant differences between macrophenotypes presented as p-heterogeneity.

resultsAmong endometriosis cases, 834 (71%) had superficial peritoneal endometriosis only, 92 (8%) had at least one endometrioma, 129 (11%) had deep lesions, and 111 (10%) had both endometrioma and deep lesions. Younger age at menarche was associated with significantly higher odds for having superficial peritoneal endometriosis only and deep + endometrioma macrophenotypes (≤11 vs 12 years-old, odds ratio = 1.29, confidence interval = 1.01-1.65 and odds ratio = 2.07, confidence interval = 1.11-3.86, respectively), but not associated with endometrioma or deep lesions alone (P-heterogeneity = .05). Presence of chronic overlapping pain conditions was associated with greater odds of endometriosis overall (odds ratio = 1.66, confidence interval = 1.49-1.85 per condition) and of superficial peritoneal endometriosis only (odds ratio = 1.80, confidence interval = 1.59-2.04 per condition) and deep lesions (odds ratio = 1.76, confidence interval = 1.44-2.15 per condition), but not with macrophenotypes including endometrioma (P-heterogeneity = .0001). Unsupervised clustering by risk factors and coexisting conditions showed distinct associative patterns by surgically-visualized lesion macrophenotypes.

conclusionThese results showing heterogeneity of individual risk factors and coexisting conditions across endometriosis macrophenotypes support the concept that endometriosis macrophenotypes may have different etiologies and underscores the importance of evaluating risk factors and biomarkers by endometriosis lesion macrophenotypes.

Indexed as

comorbiditiesendometriosismacrophenotypesrisk factors

Identifiers

PMID42641934
PMCPMC13649345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.